Yes - switching GLP-1 providers mid-treatment is clinically straightforward in most cases, though it involves some practical steps
When determined to be clinically appropriate, potential benefits may include support for metabolic processes, and circulation
Alexander Shapsis is in a unique position to evaluate how weight, metabolic health, and gastrointestinal wellness intersect
Ive also recommended Candibactin BR and Integrative Therapeutics Berberine to clients with excellent results (both are available on Fullscript
This explains why GLP-1 receptor agonists like Ozempic and Wegovy are used for diabetes and weight loss treatments, as they help regulate blood sugar and promote weight loss while protecting the heart
In an analysis of 11 studies, alpha-lipoic acid significantly lowered levels of the inflammatory marker C-reactive protein (CRP) in adults with high levels of CRP (29)